Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2014
03/04/2014US8663692 Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
03/04/2014US8663691 Gel composition for shower filter, method for manufacturing shower gel filter and shower filter
03/04/2014US8663690 Method for nanoencapsulation
03/04/2014US8663689 Functionalized adhesive medical gel
03/04/2014US8663688 Semi-solid mucoadhesive formulations
03/04/2014US8663687 Film compositions for delivery of actives
03/04/2014US8663686 Biodegradable chitosan-PEG compositions and methods of use
03/04/2014US8663685 Sustained release aminopyridine composition
03/04/2014US8663683 Sustained-release formulations of topiramate
03/04/2014US8663682 Taste-masking coated particles, process for the preparation thereof and orodispersible tablets containing said coated particles
03/04/2014US8663680 Transparent transdermal nicotine delivery devices
03/04/2014US8663678 Solid dosage form for the ocular administration of an active principle, a soluble, solid ophthalmic insert and the production method thereof
03/04/2014US8663672 Osteoimplant and method of making same
03/04/2014US8663665 Anti-chafing compositions comprising boron nitride
03/04/2014US8663664 Temperature sensitive state-changing hydrogel composition and method for their preparation
03/04/2014US8663663 Topical compositions to treat circulatory disorders
03/04/2014US8663662 Stable pharmaceutical composition and methods of using same
03/04/2014US8663661 Solid pharmaceutical dosage form of ticagrelor
03/04/2014US8663660 Polymerized micelles
03/04/2014US8663659 Orally administrable films
03/04/2014US8663657 Nucleic acid constructs
03/04/2014US8663625 Diffusively permeable monolithic biomaterial with embedded microfluidic channels
03/04/2014US8663606 Method of producing a cationic liposomal preparation comprising a lipophilic compound
03/04/2014US8663605 Agent for fibers containing keratin, comprising at least one specific amphiphilic cationic polymer, at least one cationic styling polymer that is different therefrom and at least one film-forming non-ionic and/or stabilizing non-ionic polymer
03/04/2014US8663202 Wireless remote neurostimulator
03/04/2014US8663201 Infusion device
03/04/2014US8663155 Transdermal drug delivery devices having coated microprotrusions
03/04/2014US8662076 Two-part capsule with pre-closure for housing pharmaceutical preparations for powder inhalers
03/04/2014CA2737463C Freeze-dried powder preparation of tetrodotoxin and the producing method thereof
02/2014
02/28/2014CA2822371A1 Patch preparation
02/27/2014WO2014032026A1 Ophthalmic formulation of polyoxyl lipid or polyoxyl fatty acid and treatment of ocular conditions
02/27/2014WO2014031958A1 Chemical compositions and methods for enhancing transdermal delivery of therapeutic agents
02/27/2014WO2014031897A1 Oral dosage forms having a high loading of (n,n- diethylcarbamoyl)methyl methyl|(2e)but-2-ene-1,4-dioate
02/27/2014WO2014031894A1 Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
02/27/2014WO2014031892A1 Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
02/27/2014WO2014031844A1 Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects
02/27/2014WO2014031676A1 Process for manufacturing drug delivery formulations
02/27/2014WO2014031504A1 Novel formulations and uses for curcuma extracts
02/27/2014WO2014031491A2 Extended production of nitric oxide from microencapsulated chemical reactants
02/27/2014WO2014031422A1 Novel hydroxyalkyl methyl cellulose acetate succinates
02/27/2014WO2014031419A1 Novel esterified cellulose ethers of high molecular weight and homogeneity
02/27/2014WO2014031418A1 Partially cross-linked esterified cellulose ethers
02/27/2014WO2014031242A1 Retinoids and use thereof
02/27/2014WO2014031177A1 Trans-clomiphene formulations and uses thereof
02/27/2014WO2014031034A1 Pharmaceutical compositions containing ipidacrine and use thereof to treat potency disorders and other sexual activity disorders
02/27/2014WO2014030913A1 Poly(4-hydroxybutyrate)-b-monomethoxy(polyethylene glycol) copolymer nanoparticles, production method for same and pharmaceutical composition for brain disorder treatment containing same as active ingredient
02/27/2014WO2014030715A1 Boron cluster-modified peg lipid derivative, and molecular assembly using same
02/27/2014WO2014030708A1 Preparation for preventing or treating type i diabetes
02/27/2014WO2014030656A1 Medicament-containing hollow particle
02/27/2014WO2014030605A1 Nutritional composition
02/27/2014WO2014030601A1 Method for producing novel nano-bubble poly-lipo-plex having anionic property
02/27/2014WO2014030204A1 Medicament-containing hollow particle
02/27/2014WO2014030172A2 Pharmaceutical formulations of rufinamide
02/27/2014WO2014030051A1 Stable pharmaceutical compositions comprising saxagliptin
02/27/2014WO2014029953A1 Hot melt extruded (hme) pharmaceutical composition of cinacalcet
02/27/2014WO2014029841A1 Extended release compositions of an aminoalkyl nitrate
02/27/2014WO2014029783A1 Method for freeze drying a bacteria-containing concentrate
02/27/2014WO2014029780A1 Companion cosmetic compositions
02/27/2014WO2014029765A1 Potassium containing preparation, process for the production thereof and use thereof
02/27/2014WO2014029758A1 Method for optimizing a process for freeze drying a bacteria-containing concentrate
02/27/2014WO2014029464A1 Solid pharmaceutical preparation containing levothyroxine
02/27/2014WO2014029285A1 Use of cordycepin in manufacture of medicaments for anti-depression
02/27/2014WO2014028999A1 Essential oil microparticles and uses thereof for preventing enteric diseases
02/27/2014WO2013178802A3 Microparticles and a system and method for the synthesis of microparticles
02/27/2014WO2013178788A3 Manufacture of degarelix
02/27/2014WO2013177421A3 Lipid-coated albumin nanoparticle compositions and methods of making and method of using the same
02/27/2014WO2013142611A3 Silk reservoirs for drug delivery
02/27/2014WO2013132457A3 Nanocrystalline solid dispersion compositions and process of preparation thereof
02/27/2014WO2012142137A3 Capsules comprising an emulsified syrup and methods of making the same
02/27/2014US20140058356 In Situ Blood Vessel and Aneurysm Treatment
02/27/2014US20140058340 Eyelid Margin Wipes Comprising Chemical Means For Temperature Adjustment
02/27/2014US20140058199 Method for determining measured data from the stomach of a patient
02/27/2014US20140058008 Ocular Lens
02/27/2014US20140057983 Eye drops for treatment of conjunctivochalasis
02/27/2014US20140057981 Self-emulsifying composition of omega3 fatty acid
02/27/2014US20140057975 Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes
02/27/2014US20140057872 Dosage forms of risedronate
02/27/2014US20140056997 Use of low molecular weight amino alcohols in ophthalmic compositions
02/27/2014US20140056985 Method for production of particles of pharmaceutical substances and the use thereof
02/27/2014US20140056984 Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
02/27/2014US20140056982 Enhanced Carriers For The Delivery of Microparticles To Bodily Tissues And Fluids
02/27/2014US20140056981 Method for producing drug-loaded polymeric nanoparticles by polymerization in presence of drugs
02/27/2014US20140056980 Delayed release drug formulation
02/27/2014US20140056979 Controlled Release Pharmaceutical Dosage Forms
02/27/2014US20140056978 Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof
02/27/2014US20140056977 Solid pharmaceutical composition containing 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (c)chromen-3-yl sulfamate and polymorphs thereof
02/27/2014US20140056975 Pharmaceutical Composition
02/27/2014US20140056974 Spontaneously Dispersible N-Benzoyl Staurosporine Compositions
02/27/2014US20140056973 Oral Dosage Forms Having a High Loading of a Methyl Hydrogen Fumarate Prodrug
02/27/2014US20140056972 Anti-dclk1 monoclonal antibodies and methods of production and use thereof
02/27/2014US20140056971 Delivery of ibuprofen and other compounds
02/27/2014US20140056970 Efficient method for loading amphoteric liposomes with nucleic acid active substances
02/27/2014US20140056968 Liposome formulation comprising an anti-tumour active substance, method for its preparation and pharmaceutical compositions comprising it
02/27/2014US20140056965 Method and system for treating depression or epilepsy
02/27/2014US20140056963 Extended production of nitric oxide from a microencapsulated nitrite salt and an aqueous acidified gel
02/27/2014US20140056962 Drug delivery system
02/27/2014US20140056961 Platinum-catalyzed intravaginal rings
02/27/2014US20140056957 Extended production of nitric oxide from microencapsulated chemical reactants
02/27/2014US20140056949 Controlled Release Mucoadhesive Systems
02/27/2014US20140056947 Virus traps
1 ... 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 ... 2991